A next-generation, off-the-shelf car-inkt cell therapy for multiple myeloma
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110882
- Recipient
-
University Of California, LOS Angeles UEI RN64EPNH8JC6
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,559,999
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Los Angeles, CA 90024, USA
Award details come from USAspending.gov.
About this award
The University of California, Los Angeles (UCLA) was awarded a $1,559,999 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420).
The grant will fund the development of an off-the-shelf car-inkt cell therapy for the treatment of multiple myeloma. The therapy will be developed and tested at UCLA's Office of Research Administration facilities in Los Angeles, California over a three-year period concluding September 2024. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative medical solutions for battlefield wounds and other health issues. This award advances that mission by investigating a new cell therapy approach for multiple myeloma that could benefit both military service members and civilians.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $1,559,999 |
Quick answers
Who received award W81XWH2110882?
W81XWH2110882 was awarded to University Of California, LOS Angeles by Medical Command (Department of the Army) on September 15, 2021.
How much is award W81XWH2110882 worth?
$1,559,999 has been obligated on W81XWH2110882.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award